# Mitochondrial DNA Deletions in Plasma as a Diagnostic Aid for Females Presenting With Symptoms of Endometriosis

> **NCT06907550** · — · NOT_YET_RECRUITING · sponsor: **Pearsanta, Inc** · enrollment: 1000 (estimated)

## Conditions studied

- Endometriosis

## Interventions

- **DIAGNOSTIC_TEST:** The Mitomic Endometriosis Test (MET) blood test for early detection of endometriosis

## Key facts

- **NCT ID:** NCT06907550
- **Lead sponsor:** Pearsanta, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2030-04
- **Final completion:** 2030-04
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06907550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06907550, "Mitochondrial DNA Deletions in Plasma as a Diagnostic Aid for Females Presenting With Symptoms of Endometriosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06907550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*